697 related articles for article (PubMed ID: 37998330)
1. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.
Maiese K
Cells; 2023 Nov; 12(22):. PubMed ID: 37998330
[TBL] [Abstract][Full Text] [Related]
2. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
Maiese K
Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
[TBL] [Abstract][Full Text] [Related]
4. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
Maiese K
Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
[TBL] [Abstract][Full Text] [Related]
5. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
6. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
Maiese K
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238686
[TBL] [Abstract][Full Text] [Related]
7. Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease.
Maiese K
Neural Regen Res; 2015 Apr; 10(4):518-28. PubMed ID: 26170801
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
Maiese K
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
[No Abstract] [Full Text] [Related]
9. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
10. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
Maiese K
Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
[TBL] [Abstract][Full Text] [Related]
11. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Maiese K
Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
[TBL] [Abstract][Full Text] [Related]
12. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
Maiese K
Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
[TBL] [Abstract][Full Text] [Related]
13. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
14. Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease.
Maiese K
J Transl Sci; 2016; 1(3):83-85. PubMed ID: 26893943
[TBL] [Abstract][Full Text] [Related]
15. Programming apoptosis and autophagy with novel approaches for diabetes mellitus.
Maiese K
Curr Neurovasc Res; 2015; 12(2):173-88. PubMed ID: 25742566
[TBL] [Abstract][Full Text] [Related]
16. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
17. Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.
Maiese K
Biomed Pharmacother; 2008; 62(4):218-32. PubMed ID: 18342481
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin and diabetes mellitus.
Maiese K
World J Diabetes; 2015 Oct; 6(14):1259-73. PubMed ID: 26516410
[TBL] [Abstract][Full Text] [Related]
19. Disease onset and aging in the world of circular RNAs.
Maiese K
J Transl Sci; 2016; 2(6):327-329. PubMed ID: 27642518
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
Maiese K
Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
